Epigenetic drug discovery - bromodomains and chromodomains

Epigenetics describes the management of the genetic code to influence protein expression in cells and organisms. It is a major driver of cellular transformation in cancer and many other diseases. We are developing novel inhibitors of bromodomain and chromodomain epigenetic regulators, utilizing structure-based drug design principles, stereoselective synthesis, with biochemical and cell based assays.

Enhanced research experiences